Interestingly, up-regulating GPR30 was also found in high-risk endometrial cancer patients with lower survival rates (9) and in tamoxifen-resistant breast cancer cells through the EGFR/ERK transduction pathway (49). The gene discussed is EGFR; the disease is breast carcinoma.